Semaglutide may lead to rare eye condition, study shows
A recent study published in JAMA Ophthalmology has highlighted a potential link between semaglutide, a medication commonly used for diabetes and weight loss, and a rare eye condition known as nonarteritic anterior ischemic optic neuropathy (NAION), which can lead to blindness. Key findings of the study A significant association was found between the use of […]
Nutritional guidelines for GLP-1 medication users
Recent studies have highlighted the importance of tailored nutritional guidelines for individuals using GLP-1 medications for weight loss. These drugs, effective in reducing appetite and aiding significant weight loss, include FDA-approved Wegovy and others like Ozempic and Saxenda used off-label. However, the reduced food intake associated with these medications raises concerns about potential nutritional deficiencies. […]
Zepbound: A promising anti-obesity medication for individuals with chronic conditions
New research highlights the effectiveness of the anti-obesity medication Zepbound (tirzepatide) in promoting significant weight loss, even for individuals with multiple obesity-related chronic conditions. This groundbreaking study challenges the previous belief that chronic health issues hinder weight loss efforts. Understanding obesity and its associated chronic conditions Obesity is a major health concern that can lead […]